XML 28 R15.htm IDEA: XBRL DOCUMENT
v3.20.4

Allowance for Doubtful Accounts | 12 Months Ended
--- | ---
Dec. 31, 2020
Receivables [Abstract] |
Allowance for Doubtful Accounts | Note 8 — Allowance for Doubtful Accounts On January 1, 2020 (the "adoption date"), the Company replaced its previous incurred loss impairment model for estimating credit losses on accounts and notes receivables with an expected loss model prepared in accordance with ASC 326. While the incurred loss impairment model had the Company recognize credit losses when it was probable that a loss had been incurred, ASC 326 requires the Company to estimate future expected credit losses on such instruments before an impairment may occur. On the adoption date, the Company recorded an initial increase of $42.2 million to the Company's allowance for doubtful accounts, with an offset recorded as an opening adjustment to retained earnings. In making the Company’s credit evaluations, management considers the general collection risk associated with trends in the long-term care industry. The Company establishes credit limits through payment terms with customers, performs ongoing credit evaluations and monitors accounts on an aging schedule basis to minimize the risk of loss. Despite the Company’s efforts to minimize credit risk exposure, customers could be adversely affected if future industry trends, including those related to COVID-19, change in such a manner as to negatively impact their cash flows. The full effects of COVID-19 on the Company’s customers are highly uncertain and cannot be predicted. As a result, the Company’s future collection experience can differ significantly from historical collection trends. If the Company’s customers experience a negative impact on their cash flows, it could have a material adverse effect on the Company’s results of operations and financial condition. The Company evaluates its accounts and notes receivable for expected credit losses quarterly. Accounts receivables are evaluated based on internally developed credit quality indicators derived from the aging of receivables. Notes receivable are evaluated based on internally developed credit quality indicators derived from Management’s assessment of collection risk. The Company manages note receivable portfolios using a two tiered approach by disaggregating standard notes receivables, which are promissory notes in good standing, from those who have been identified by Management as having an elevated credit risk profile due to a trigger event such as bankruptcy. At the end of each period the Company sets a reserve for expected credit losses on standard notes receivable based on the Company’s historical loss rate. Notes receivable with an elevated risk profile, which are from customers who have filed bankruptcy, are subject to collections activity or are slow payers that are experiencing financial difficulties, are aggregated and evaluated to determine the total reserve for the class of receivable. The guidance in ASC 326 permits entities to make an accounting policy election not to measure an estimate for credit losses on accrued interest if those entities write-off accrued interest deemed uncollectible in a timely manner. The Company follows an income recognition policy on all interest earned on notes receivable. Under such policy the Company accounts for all notes receivable on a non-accrual basis and defers the recognition of any interest income until receipt of cash payments. This policy was established, recognizing the environment of the long-term care industry, and not because such notes receivable are necessarily impaired. Accordingly, the Company does not record a credit loss adjustment for accrued interest. For the year ended December 31, 2020, the Company recognized $1.7 million in interest income from notes receivables. As part of the Company’s adoption of ASC 326, there are additional disclosures required to be made on a class of financing receivable basis. The following table presents the Company’s two tiers of notes receivable further disaggregated by year of origination, as well as write-off activity for the year ended December 31, 2020:
|  | Notes Receivable
|  | Amortized Cost Basis by Origination Year
|  | 2020 |  | 2019 |  | 2018 |  | 2017 |  | 2016 |  | Prior |  | Total
|  | (in thousands)
Notes Receivable |  |  |  |  |  |  |  |  |  |  |  |  |  |
Standard notes receivable |  | $ | 12,592 |  |  | $ | 10,474 |  |  | $ | 19,185 |  |  | $ | 22,566 |  |  | $ | 28 |  |  | $ | 1,573 |  |  | $ | 66,418 |
Elevated risk notes receivable |  | $ | — |  |  | $ | 617 |  |  | $ | — |  |  | $ | 3,969 |  |  | $ | — |  |  | $ | 1,374 |  |  | $ | 5,960 |
Current-period gross write-offs |  | $ | — |  |  | $ | — |  |  | $ | 1,748 |  |  | $ | 1,540 |  |  | $ | 1,970 |  |  | $ | 67 |  |  | $ | 5,325 |
Current-period recoveries |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Current-period net write-offs |  | $ | — |  |  | $ | — |  |  | $ | 1,748 |  |  | $ | 1,540 |  |  | $ | 1,970 |  |  | $ | 67 |  |  | $ | 5,325 |
The following table provides information as to the status of payment on the Company’s notes receivable which were past due as of December 31, 2020:
|  | Age Analysis of Past-Due Notes Receivable as of December 31, 2020
|  | 0-90 Days |  | 91 - 180 Days |  | Greater than 181 Days |  | Total
|  | (in thousands)
Notes Receivable |  |  |  |  |  |  |  |
Standard notes receivable |  | $ | 1,001 |  |  | $ | 3,794 |  |  | $ | 3,712 |  |  | $ | 8,507 |
Elevated risk notes receivable |  | 253 |  |  | 330 |  |  | 5,377 |  |  | 5,960 |
|  | $ | 1,254 |  |  | $ | 4,124 |  |  | $ | 9,089 |  |  | $ | 14,467 |
The following table provides a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the year ended December 31, 2020:
|  | Allowance for doubtful accounts
Portfolio Segment: |  | December 31, 2019 |  | Cumulative effect of ASC 326 adoption 1 |  | Write-Offs 2 |  | Bad Debt Expense |  | December 31, 2020
|  | (in thousands)
Accounts receivable |  | $ | 39,903 |  |  | $ | 36,709 |  |  | $ | (31,139) |  |  | $ | 5,579 |  |  | $ | 51,052 |
Notes receivable |  |  |  |  |  |  |  |  |  |
Standard notes receivable |  | $ | 6,667 |  |  | $ | 5,236 |  |  | $ | (2,238) |  |  | $ | 3,593 |  |  | $ | 13,258 |
Elevated risk notes receivable |  | 5,823 |  |  | 291 |  |  | (3,087) |  |  | 464 |  |  | 3,491 |
Total notes receivable |  | $ | 12,490 |  |  | $ | 5,527 |  |  | $ | (5,325) |  |  | $ | 4,057 |  |  | $ | 16,749 |
Total accounts and notes receivable |  | $ | 52,393 |  |  | $ | 42,236 |  |  | $ | (36,464) |  |  | $ | 9,636 |  |  | $ | 67,801 |
1.Represents the pre-tax one-time adjustment to the Company’s 2020 opening retained earnings balance in accordance with the adoption of the CECL accounting guidance. 2.Write-offs are shown net of recoveries. During the year ended December 31, 2020, the Company collected $1.0 million of accounts receivables that were recovered subsequent to being written-off. Prior to the adoption date, the allowance for doubtful accounts was established when the Company had determined that receivables have been impaired and the Company could reasonably estimate the amount of the incurred loss. The allowance for doubtful accounts was evaluated based on the Company’s ongoing review of accounts and notes receivable and was inherently subjective as it required estimates susceptible to significant revision as more information became available. For the years ended December 31, 2019 and 2018 the Company recorded bad debt provisions (in an Allowance for Doubtful Accounts) of $25.5 million and $51.4 million, respectively. Impaired Notes Receivable Prior to the adoption date, the Company evaluated its notes receivable for impairment quarterly and on an individual customer basis. Notes receivable were generally evaluated for impairment when the respective customers were in bankruptcy, were subject to collections activity or were slow payers that were experiencing financial difficulties. In the event that the evaluation resulted in a determination that a note receivable was impaired, it was valued at the present value of expected future cash flows or at the market value of related collateral. A summary schedules of impaired notes receivable, and the related reserve, for the years ended December 31, 2019 and 2018 was as follows:
|  | Impaired Notes Receivable
Year Ended December 31, |  | Balance Beginning of Year |  | Additions |  | Deductions |  | Balance End of Year |  | Average Outstanding Balance
|  | (in thousands)
2019 |  | $ | 25,704 |  |  | $ | 3,763 |  |  | $ | 4,830 |  |  | $ | 24,637 |  |  | $ | 27,554 |
2018 |  | $ | 6,854 |  |  | $ | 23,382 |  |  | $ | 4,532 |  |  | $ | 25,704 |  |  | $ | 15,448 |
|  | Reserve for Impaired Notes Receivable
Year Ended December 31, |  | Balance Beginning of Year |  | Additions |  | Deductions |  | Balance End of Year
|  | (in thousands)
2019 |  | $ | 13,472 |  |  | $ | 3,575 |  |  | $ | 4,557 |  |  | $ | 12,490 |
2018 |  | $ | 2,884 |  |  | $ | 12,526 |  |  | $ | 1,938 |  |  | $ | 13,472 |

X
- Definition The entire disclosure for allowance for credit losses. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -URI http://asc.fasb.org/topic&trid=2196771 + Details
Name: | us-gaap_AllowanceForCreditLossesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ReceivablesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration